🌟 Partner with Pharmaceuticals 2024! 🌟 Calling all societies in pharma and healthcare! Be a part of Pharmaceuticals 2024, the premier conference for pharma innovation, while we celebrate Pharmaceuticals' 20th anniversary. Partner with us to connect, grow, and lead in the industry. 🤝 As a partner, enjoy benefits such as reduced registration fees for your members and prominent logo display on our website, enhancing your society's visibility. Let’s innovate, collaborate, and grow together! 📧 pharmaceuticals2024@mdpi.com | 🌐 https://bit.ly/4cCwfxM
Sciforum’s Post
More Relevant Posts
-
Real world outcomes measurement is no longer a nice to have for life science industry. Post launch evidence generation requirements by HTA bodies makes it necessity to have established partnerships in place to collect real time outcomes together with healthcare providers. Join us to discuss the topic in our webinar!
Join our webinar on May 30th to discover how Value-Based Healthcare (VBHC) is reshaping the pharmaceutical industry. Learn from experts Vesa Komssi, Nordic Healthcare Group's Executive Vice President, and Mark Tolboom, partner at Vintura, about enhancing patient access to innovative therapies and successful VBHC initiatives. Explore the power of partnership in driving innovation and improving treatment outcomes. Register now for insights into building a patient-centric healthcare system: https://lnkd.in/diC_Z6RU #EUHTA #VBHC #ValueBasedHealthcare #PatientOutcomes #HealthcareTransformation
To view or add a comment, sign in
-
-
Partner at NHG | Consulting | Governmental affairs | Stakeholder | PPP | Policy | Strategy | Public procurement | Management | Public Affairs |
Get an insight into how pharma is using VBHC! And get some pointers from my colleague Vesa Komssi!
Join our webinar on May 30th to discover how Value-Based Healthcare (VBHC) is reshaping the pharmaceutical industry. Learn from experts Vesa Komssi, Nordic Healthcare Group's Executive Vice President, and Mark Tolboom, partner at Vintura, about enhancing patient access to innovative therapies and successful VBHC initiatives. Explore the power of partnership in driving innovation and improving treatment outcomes. Register now for insights into building a patient-centric healthcare system: https://lnkd.in/diC_Z6RU #EUHTA #VBHC #ValueBasedHealthcare #PatientOutcomes #HealthcareTransformation
To view or add a comment, sign in
-
-
Cocreating Impact in Medical Affairs & Market Access | Medical Transformation & EU HTA Specialist | Strategy Consulting | Life Sciences & Healthcare
Interested in #ValueBasedHealthcare (#VBHC)? Join the webinar, in which our Vintura partner Mark Tolboom will share his expertise and vast experience! Register using the link below!
🔊Join our webinar on May 30, 2024, to discover how Value-Based Healthcare (VBHC) is reshaping the pharmaceutical industry. Learn from experts Vesa Komssi Executive Vice President at Nordic Healthcare Group , and Mark Tolboom, partner at Vintura, about enhancing patient access to innovative therapies and successful VBCH initiatives. Explore the power of partnership in driving innovation and improving treatment outcomes. Register now for insights into building a patient-centric healthcare system: https://lnkd.in/dxz5aHC3 #EUHTA #VBHC #ValueBasedHealthcare #PatientOutcomes #HealthcareTransformation
To view or add a comment, sign in
-
-
Strategy Consultant at Vintura | Life Sciences | Patient-centricity, Value, Access and Policy, Market Access
Last week Mark Tolboom and Vesa Komssi hosted an interesting webinar on how Value-Based Healthcare is reshaping the pharmaceutical industry. Specifically, they shared insights into the value of partnerships in healthcare and the rising importance of evidence generation. No worries if you were not able to join, you can have a look at the recording or linked materials via the following link: https://lnkd.in/dxz5aHC3 #VBHC #ValueBasedPartnerships #VBP #PatientOutcomes #IntegratedEvidenceGeneration
🔊Join our webinar on May 30, 2024, to discover how Value-Based Healthcare (VBHC) is reshaping the pharmaceutical industry. Learn from experts Vesa Komssi Executive Vice President at Nordic Healthcare Group , and Mark Tolboom, partner at Vintura, about enhancing patient access to innovative therapies and successful VBCH initiatives. Explore the power of partnership in driving innovation and improving treatment outcomes. Register now for insights into building a patient-centric healthcare system: https://lnkd.in/dxz5aHC3 #EUHTA #VBHC #ValueBasedHealthcare #PatientOutcomes #HealthcareTransformation
To view or add a comment, sign in
-
-
The ISPOR Patient Representatives Roundtable – Europe is now taking place with the participation of over 20 patient representatives and key stakeholders, including researchers, payers, policymakers, HTA bodies, and the biopharmaceutical industry. The discussion is focused on Joint Clinical Assessment and its potential to improve the patient experience in HTA involvement. A special thank you to Derick Mitchell, Chair of the Roundtable for his leadership and speakers Sophie Werkö, Anke-Peggy Holtorf, and Valentina Strammiello for providing the attendees with exceptional presentations on #JCA and #patientinvolvement, #PICO, and specific training for patients. #ISPOREurope #HTA #EUCAPA #eupati
To view or add a comment, sign in
-
-
Clinical trials are conducted in phases, each designed to answer specific questions about a new treatment. By understanding these phases, we can better appreciate the complexity and importance of clinical research. 👩🔬🔬💊 Swipe to learn more about the different phases of clinical trials and their significance! 🩺 Medcare Pharma: Your Way to Cure Contact us: ☎️ | 1-866-4-MEDICINE 📧 | info@medcarepharma.care 🌐 | https://lnkd.in/gA9pPUVR #healthcarerevolution #clinicaltrial #clinicalresearch #medicalresearch #clinicalstudies #clinicalstudy #healthcare #medcarepharma #researchstudies
-
-
-
-
-
+1
To view or add a comment, sign in
-
-
The IFPMA Decision-making Framework is a very helpful tool based on the IFPMA Ethos. 👍
As a science-based industry that delivers medical breakthroughs for healthier futures, what we do and how we do things matters. Given the fast pace of medical innovation and the evolving environment in which we operate, IFPMA has developed a structured approach to support innovative pharmaceutical companies and associations make decisions that are grounded in our Ethos. The five-phase Ethos in Action Decision-Making Framework integrates compliance, integrity, and ethical considerations into day-to-day business activities, supporting thoughtful decisions that meet patient and societal needs. Discover IFPMA’s suite of materials to support ethical decision-making: https://ifpma.info/43a5RrR Sobia Akram (Novo Nordisk), Uma Swaminathan (GSK), Matt Rotelli (Eli Lilly and Company), Dominique Laymand (Clifford Chance), Maike Bermueller (Merz Therapeutics), Julie BONHOMME (EFPIA - European Federation of Pharmaceutical Industries and Associations), Claudia Cappellazzo (Novartis), Kristin Campisi (Bristol Myers Squibb), Julien Durand (Sanofi), Karen L. Eryou (Ethicist International), Lindsay Havern (Pfizer), Loreto Fernández- Oronoz Martín de Vidales (FARMAINDUSTRIA), Juan Paillás Lehmann (Merck), Minal Patel (Johnson & Johnson), Kiko Tranquilino (#PHAP)
To view or add a comment, sign in
-
Partnerships between the NHS and the pharmaceutical industry can bring significant benefits - including better patient outcomes, reduced operational pressures, and more preventative care – but there are practical and cultural barriers standing in the way. Together with the ABPI we convened 80 senior NHS and industry leaders for a series of masterclasses to explore how ICSs and industry can work better together. Our new joint report, complemented by ABPI’s library of 120 good practice case studies, shares the learning from those sessions as well as making some tangible recommendations which aim to support ICS in overcoming the challenges they face and help demonstrate the role cross-sector partnerships can play in helping to overcome them. Learn more 🔗 https://bit.ly/47OjMoD
To view or add a comment, sign in
-
-
MHN is exhibiting at next week's World of Pharmaceutical Market Research conference. Stop by our booth to meet Susan Owens and Andrew Hayes to learn about gaining access to MHN's proprietary panels featuring PATIENTS, PHYSICIANS, and HOSPITAL EXECUTIVES. #mrx #healthcareresearch #qualitativeresearch #MHN #aitransformation #quanitativeresearch #insights #marketingideas #howtoqualitative #PMRC #Quirks
To view or add a comment, sign in
-
-
🔍 Bridging the Gap in Osteoporosis Management: A Case Study A multinational pharmaceutical leader in bone health partnered with The Rounds to address a critical knowledge gap in osteoporosis among physicians. Through dynamic peer-learning programs led by esteemed specialists, we achieved excellent physician engagement and learning outcomes. 🌟 Highlights: – Almost 12,000 verified physician impressions – Enhanced understanding of osteoporosis management Discover how we can elevate physician engagement together: https://lnkd.in/eQQJ8d2Q #OsteoporosisAwareness #KnowledgeExchange #TheRounds
To view or add a comment, sign in